Inhalation Sedatives Market Growth Outlook Through 2024-2033

Overview and Scope
Inhalation sedatives refer to a relaxing agent used with a nose mask. In high doses, inhalation sedatives can be used as a general anaesthetic, a calming agent, and to treat sleep disorders. Inhalation sedation is the continuous administration of a tranquillizer through a nose mask. The method has also been referred to as “”happy gas,”” laughing gas,”” or “”conscious sedation. The gas is actually known as nitrous oxide.

Sizing and Forecast
The inhalation sedatives market size has grown steadily in recent years. It will grow from $2.24 billion in 2023 to $2.34 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, growing geriatric population, rising awareness of inhalation sedatives, increasing investment in research and development, expanding pipeline of inhalation sedatives, surgical procedures.

The inhalation sedatives market size is expected to see steadily grown in the next few years. It will grow to $2.88 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to rising demand for outpatient procedures, anesthesia delivery systems, telemedicine and remote monitoring, growing prevalence of respiratory disorders, expansion of ambulatory surgery centers. Major trends in the forecast period include non-pharmacological alternatives, sustainability and eco-friendly practices, data integration and artificial intelligence, advancements in medical technology.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/inhalation-sedative-global-market-report

Segmentation & Regional Insights
The inhalation sedatives market covered in this report is segmented –

1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide
2) By Application: Induction, Maintenance
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

North America was the largest region in the inhalation sedatives market in 2023. The regions covered in the inhalation sedatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=3468&type=smp

Major Driver Impacting Market Growth
The short onset and duration times of inhalation sedatives market are expected to drive the inhalation sedative market. Because of the rapid onset of the inhalation sedative and the quick recovery rate, it is appropriate for short procedures, particularly dental surgeries in pediatrics and intensive care units for pain reduction and quick recovery. Nitrous oxide, for example, is the most commonly used inhaled sedative. It is administered as a mixture of 30-70% oxygen, takes about 1-2 minutes to act, and has a 5-minute duration of action. The short time required for the onset of action and its short duration makes nitrous oxide the most used inhalation sedative for dental treatment. As a result, the inhalation sedatives market is expected to be driven by their short onset and duration times.

Key Industry Players

Major companies operating in the inhalation sedatives market include AbbVie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co. Ltd., Lunan Pharmaceutical Group Co. Ltd., Novartis International AG, Piramal Enterprises Ltd., Troikaa Pharmaceuticals Ltd., AstraZeneca PLC, Boehringer Ingelheim International GmbH, Merck & Co. Inc., Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Zydus Cadila Health Care Limited, Torrent Pharmaceuticals Ltd., Aurobindo Pharma Limited, Intas Pharmaceuticals Ltd., Wockhardt Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Jubilant Life Sciences Limited

The inhalation sedatives market report table of contents includes:

1. Executive Summary
2. Inhalation Sedatives Market Characteristics
3. Inhalation Sedatives Market Trends And Strategies
4. Inhalation Sedatives Market – Macro Economic Scenario
5. Global Inhalation Sedatives Market Size and Growth
.
.
.
31. Global Inhalation Sedatives Market Competitive Benchmarking
32. Global Inhalation Sedatives Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Inhalation Sedatives Market
34. Inhalation Sedatives Market Future Outlook and Potential Analysis
35. Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model